Roche Agrees to Acquire Poseida Therapeutics for $1.5 Billion
Roche to Acquire Poseida Therapeutics in a Major $1.5 Billion Deal In a significant move that underscores the growing importance of innovative therapies in the pharmaceutical landscape, Roche has announced its agreement to acquire Poseida … Read more